Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gleave

Showing results (71-80 of 258) with videos related to

Pageof 26
Sort By:
Scientific Reports|November 14, 2015
Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axisXiaoyong Hu, Consuelo Garcia, Ladan Fazli, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation controlYue Yu, Liangliang Liu, Ning Xie, et al.
Cancer Research|February 22, 2012
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cellsDavid J Mulholland, Naoko Kobayashi, Marcus Ruscetti, et al.
World Journal of Urology|November 9, 2017
A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancerSebastian Karl Frees, Jonathan Aning, Peter Black, et al.
Radiation Research|December 31, 2004
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stagesKirsten Skov, Hans Adomat, Mary Bowden, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potentialBenjamin Van Espen, Htoo Zarni Oo, Colin Collins, et al.
Cancer Research|September 18, 2004
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancerPalma Rocchi, Alan So, Satoko Kojima, et al.
Chemmedchem|June 18, 2009
PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cellsXiao-Xuan Liu, Palma Rocchi, Fan-Qi Qu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 14, 2009
Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinomaElie Hadchity, Marie-Thérèse Aloy, Christian Paulin, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Pageof 26

Showing results (71-80 of 258) with videos related to

Sort By:
Pageof 26
Scientific Reports|November 14, 2015
Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axisXiaoyong Hu, Consuelo Garcia, Ladan Fazli, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation controlYue Yu, Liangliang Liu, Ning Xie, et al.
Cancer Research|February 22, 2012
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cellsDavid J Mulholland, Naoko Kobayashi, Marcus Ruscetti, et al.
World Journal of Urology|November 9, 2017
A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancerSebastian Karl Frees, Jonathan Aning, Peter Black, et al.
Radiation Research|December 31, 2004
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stagesKirsten Skov, Hans Adomat, Mary Bowden, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potentialBenjamin Van Espen, Htoo Zarni Oo, Colin Collins, et al.
Cancer Research|September 18, 2004
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancerPalma Rocchi, Alan So, Satoko Kojima, et al.
Chemmedchem|June 18, 2009
PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cellsXiao-Xuan Liu, Palma Rocchi, Fan-Qi Qu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 14, 2009
Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinomaElie Hadchity, Marie-Thérèse Aloy, Christian Paulin, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Pageof 26